Last reviewed · How we verify

PURETHAL Mites 50,000 AUeq/ml

HAL Allergy · Phase 3 active Biologic

PURETHAL Mites 50,000 AUeq/ml is a Allergen immunotherapy (sublingual) Biologic drug developed by HAL Allergy. It is currently in Phase 3 development for Allergic rhinitis and/or allergic asthma caused by dust mite allergens.

PURETHAL Mites is an allergen immunotherapy that desensitizes the immune system to dust mite allergens through gradual exposure to standardized mite extract.

PURETHAL Mites is an allergen immunotherapy that desensitizes the immune system to dust mite allergens through gradual exposure to standardized mite extract. Used for Allergic rhinitis and/or allergic asthma caused by dust mite allergens.

At a glance

Generic namePURETHAL Mites 50,000 AUeq/ml
SponsorHAL Allergy
Drug classAllergen immunotherapy (sublingual)
TargetDust mite allergens (Der p and Der f proteins)
ModalityBiologic
Therapeutic areaImmunology / Allergy
PhasePhase 3

Mechanism of action

This product contains a standardized extract of dust mite allergens (measured in AUeq/ml units) administered as sublingual immunotherapy. It works by inducing immune tolerance through repeated low-dose exposure, shifting the immune response from IgE-mediated (allergic) to IgG-mediated (protective) antibodies and promoting regulatory T cells. Over time, this reduces allergic symptoms and the need for symptomatic medications.

Approved indications

Common side effects

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about PURETHAL Mites 50,000 AUeq/ml

What is PURETHAL Mites 50,000 AUeq/ml?

PURETHAL Mites 50,000 AUeq/ml is a Allergen immunotherapy (sublingual) drug developed by HAL Allergy, indicated for Allergic rhinitis and/or allergic asthma caused by dust mite allergens.

How does PURETHAL Mites 50,000 AUeq/ml work?

PURETHAL Mites is an allergen immunotherapy that desensitizes the immune system to dust mite allergens through gradual exposure to standardized mite extract.

What is PURETHAL Mites 50,000 AUeq/ml used for?

PURETHAL Mites 50,000 AUeq/ml is indicated for Allergic rhinitis and/or allergic asthma caused by dust mite allergens.

Who makes PURETHAL Mites 50,000 AUeq/ml?

PURETHAL Mites 50,000 AUeq/ml is developed by HAL Allergy (see full HAL Allergy pipeline at /company/hal-allergy).

What drug class is PURETHAL Mites 50,000 AUeq/ml in?

PURETHAL Mites 50,000 AUeq/ml belongs to the Allergen immunotherapy (sublingual) class. See all Allergen immunotherapy (sublingual) drugs at /class/allergen-immunotherapy-sublingual.

What development phase is PURETHAL Mites 50,000 AUeq/ml in?

PURETHAL Mites 50,000 AUeq/ml is in Phase 3.

What are the side effects of PURETHAL Mites 50,000 AUeq/ml?

Common side effects of PURETHAL Mites 50,000 AUeq/ml include Oral pruritus, Throat irritation, Mouth edema, Local allergic reactions at administration site.

What does PURETHAL Mites 50,000 AUeq/ml target?

PURETHAL Mites 50,000 AUeq/ml targets Dust mite allergens (Der p and Der f proteins) and is a Allergen immunotherapy (sublingual).

Related